The hypercalcemia of malignancy: pathogenesis and management.
about
Parathyroid hormone-related protein purified from a human lung cancer cell lineHypercalcemia of malignancy and new treatment optionsAt the crossroads: EGFR and PTHrP signaling in cancer-mediated diseases of boneClinical experience with pamidronate in the treatment of Paget's disease of bone.Renal handling of calcium and sodium in metastatic and non-metastatic malignancy.Medical management of hypercalcaemia.Mechanism of malignant hypercalcaemia in carcinoma of the breastHumoral hypercalcemia of malignancy. Release of a prostaglandin-stimulating bone-resorbing factor in vitro by human transitional-cell carcinoma cellsEstrogens and antiestrogens stimulate release of bone resorbing activity by cultured human breast cancer cellsRelative contribution of humoral and metastatic factors to the pathogenesis of hypercalcaemia in malignancy.Role of glucocorticoids in management of malignant hypercalcaemia.Hypercalcemia of malignancy revisited.Treatment of malignant hypercalcaemia.Pamidronate.Dose-response study of ibandronate in the treatment of cancer-associated hypercalcaemia.[Hypercalcemia in cancer patients. Who, when and how to treat?]Inhibition of epidermal growth factor receptor signalling reduces hypercalcaemia induced by human lung squamous-cell carcinoma in athymic mice.Parathyroid hormone-related protein, bone metastases and hypercalcaemia of malignancy.Single dose versus daily intravenous aminohydroxypropylidene biphosphonate (APD) for the hypercalcaemia of malignancyParathyroid hormone-related protein: biochemistry and molecular biology.The calcitonin gene peptides: biology and clinical relevance.Role of immune cytokines in the pathogenesis of periapical lesions.Parathyroid hormone-related protein in hypercalcaemia of malignancy.Percutaneus osteoplasty in the treatment of extraspinal painful multiple myeloma lesions.Acute management of cancer-related hypercalcemia.The pathobiology of the osteoclast.Pathogenesis of hypercalcaemia of malignancy.Ectopic hormone syndromes.Evidence that tumor necrosis factor plays a pathogenetic role in the paraneoplastic syndromes of cachexia, hypercalcemia, and leukocytosis in a human tumor in nude mice.Malignant hypercalcaemia.Parathyroid hormone-related peptide in pancreatic neuroendocrine tumours associated with hypercalcaemia.Hypercalcemia in patients of oral squamous cell carcinoma.Animal Models of Cancer-Associated Hypercalcemia.The Differences between Lymphoma and Leukemia Type of Adult T-cell Leukemia.Clinical Characteristics, Causes and Survival in 115 Cancer Patients with Parathyroid Hormone Related Protein-mediated Hypercalcemia.Production of parathyroid hormone-related protein in two new cell lines of renal cell carcinoma.Effects of Serum Albumin, Calcium Levels, Cancer Stage and Performance Status on Weight Loss in Parathyroid Hormone-Related Peptide Positive or Negative Patients with Cancer.Differences in Prognostic Factors between Diffuse Non-Hodgkin's Lymphoma and Lymphoma Type of Adult T-Cell Leukemia.
P2860
Q24604722-6193EDBD-8309-4AB2-B48D-94FC6F1E86C7Q26775300-0EC63C63-7C5F-4974-AA59-DA3F3D861DC9Q26866067-A05E5018-C4DA-4DC3-A0D4-D5B49B4AA794Q33564104-90A0CAA5-6D4D-4977-B072-01B3CD78FB98Q34284062-94E56FD3-CF8D-485A-8E25-D2BC79571F0BQ34403106-D0B70DF1-3827-471F-9679-76B5A00FC25EQ34488034-ED519137-0ECF-445F-B4C1-777969399C77Q34520760-40E2CD4D-AE12-4B08-BDB3-46CA46A495C1Q34533199-F5623461-F811-4055-BD1F-BE609EBF89B5Q34548070-7CFAA2B5-F87E-4632-81C3-68369FD8C92EQ34550824-ED733E7D-0CB6-4589-A630-96DEFF15D503Q34556063-A609FA9B-AC6C-4AE9-8438-E6483C028C0EQ34628598-F93829D8-A4BE-403F-BC44-1514FA40C5F0Q35466455-7AB71B83-6F87-4378-877E-58595C209B69Q36115924-96ABF8B6-D045-4EAD-841E-8D8C94801F2FQ36287932-853C2B2E-A6F9-43AB-9F48-5BF6B61207F6Q36610803-0142EE97-95FB-4D50-88BB-A7C332D98FE0Q36821023-BFCB8A1D-8345-43C5-B019-9AC5A366E39FQ36894850-EA9B088F-B781-4C9A-BD35-039A93970F5BQ37436735-F000C7BA-2928-4941-AAC4-2A052275C4BEQ37563624-7132D745-28F9-4873-94B3-BA26030AFA8CQ37783203-C81F93E4-942F-4552-950D-2EF0DF2AD73CQ38773936-68A9E90C-1CED-4EAA-BBFD-3BD5321FAA2FQ39285366-6D43852B-F632-4B89-B585-D4DA00B99FCAQ39465499-8AAF5E61-9C6D-4AC7-AB18-F560863E9232Q39492910-D7BE5CEE-921C-467C-B9EC-8B89F16E22D7Q39500212-B8298AA0-2FD8-4CC9-B075-C5786620F098Q39507833-90A56D72-9CA3-41E2-AC44-3FEBCA06482AQ40512172-7D9A2A8D-C255-4066-BF51-C2C6B8515459Q41888758-761A47F1-F147-4533-9177-2F0E28B639EFQ42571688-277A7F86-4C6E-40A2-942B-99DA881CD929Q42737827-E052459E-5CB4-4F17-ACE7-B22E97E804B3Q43378586-2E660A7A-3987-4DB7-A11B-E41F5DDF9295Q44657001-E85F1F61-C8A5-48D0-8C3A-FFA297D39E62Q47163131-DC795726-8D13-4413-AD75-726EF133E554Q52834183-C7F18A03-BCD7-4DC5-979D-F3A065CDF5AAQ54935754-9DA05AB2-0849-4AFF-B42E-B64D9C12DA8CQ55242091-A1974D73-3623-457A-9EC9-EF55478E8B87
P2860
The hypercalcemia of malignancy: pathogenesis and management.
description
1982 nî lūn-bûn
@nan
1982年の論文
@ja
1982年論文
@yue
1982年論文
@zh-hant
1982年論文
@zh-hk
1982年論文
@zh-mo
1982年論文
@zh-tw
1982年论文
@wuu
1982年论文
@zh
1982年论文
@zh-cn
name
The hypercalcemia of malignancy: pathogenesis and management.
@en
type
label
The hypercalcemia of malignancy: pathogenesis and management.
@en
prefLabel
The hypercalcemia of malignancy: pathogenesis and management.
@en
P1433
P1476
The hypercalcemia of malignancy: pathogenesis and management.
@en
P2093
P304
P356
10.1016/0026-0495(82)90012-9
P577
1982-12-01T00:00:00Z